These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35038340)

  • 1. Short versus prolonged courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection: a retrospective study-authors' response.
    Bae M; Jung J
    J Antimicrob Chemother; 2022 Feb; 77(3):859-860. PubMed ID: 35038340
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: Short versus prolonged courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection: a retrospective study.
    Hagiya H; Otsuka F
    J Antimicrob Chemother; 2022 Feb; 77(3):857-858. PubMed ID: 34910134
    [No Abstract]   [Full Text] [Related]  

  • 3. Short versus prolonged courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection: a retrospective study.
    Bae M; Jeong Y; Bae S; Kim MJ; Chong YP; Kim SH; Lee SO; Choi SH; Kim YS; Jung J
    J Antimicrob Chemother; 2021 Dec; 77(1):223-228. PubMed ID: 34590681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination antimicrobial therapy in Pseudomonas aeruginosa bacteremia.
    Afonso E; Conoscenti E; Blot S
    Eur J Pediatr; 2020 Dec; 179(12):1997-1998. PubMed ID: 32700233
    [No Abstract]   [Full Text] [Related]  

  • 5. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa bloodstream infections in children: a 9-year retrospective study.
    Pilmis B; Alby-Laurent F; Fasola ML; Seegers V; Guery R; Guet-Revillet H; Postaire M; Toubiana J; Bille E; Lortholary O; Zahar JR
    Eur J Pediatr; 2020 Aug; 179(8):1247-1254. PubMed ID: 32080759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment.
    Micek ST; Lloyd AE; Ritchie DJ; Reichley RM; Fraser VJ; Kollef MH
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1306-11. PubMed ID: 15793102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009528. PubMed ID: 25741986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Smith S; Waters V; Jahnke N; Ratjen F
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD009528. PubMed ID: 32520436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009528. PubMed ID: 28981972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on antimicrobial resistance and the role of newer antimicrobial agents for
    Pragasam AK; Veeraraghavan B; Nalini E; Anandan S; Kaye KS
    Indian J Med Microbiol; 2018; 36(3):303-316. PubMed ID: 30429381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD006961. PubMed ID: 28628280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.
    Smith S; Ratjen F; Remmington T; Waters V
    Cochrane Database Syst Rev; 2020 May; 5(5):CD006961. PubMed ID: 32412092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyocin efficacy in a murine model of Pseudomonas aeruginosa sepsis.
    Six A; Mosbahi K; Barge M; Kleanthous C; Evans T; Walker D
    J Antimicrob Chemother; 2021 Aug; 76(9):2317-2324. PubMed ID: 34142136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.
    Leung CH; Wang NY; Liu CP; Weng LC; Hsieh FC; Lee CM
    J Microbiol Immunol Infect; 2008 Dec; 41(6):491-8. PubMed ID: 19255693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-acquired Pseudomonas aeruginosa sepsis in previously healthy infants and children: analysis of forty-three episodes.
    Huang YC; Lin TY; Wang CH
    Pediatr Infect Dis J; 2002 Nov; 21(11):1049-52. PubMed ID: 12442028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral treatment of systemic Pseudomonas aeruginosa infection with enoxacin.
    Hubrechts JM; Vanhoof R; Servais J; Toen R; Sacré J; van Gysel JP
    Lancet; 1984 Apr; 1(8381):860. PubMed ID: 6143180
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of short-incubation MALDI-TOF MS on empiric antibiotic therapy in bloodstream infections caused by Pseudomonas aeruginosa, Enterococcus spp. and AmpC-producing Enterobacteriaceae.
    Halavaara M; Nevalainen A; Martelius T; Kuusela P; Anttila VJ
    Diagn Microbiol Infect Dis; 2019 May; 94(1):1-6. PubMed ID: 30554845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shrimp (Penaeus monodon) anti-lipopolysaccharide factor reduces the lethality of Pseudomonas aeruginosa sepsis in mice.
    Pan CY; Chao TT; Chen JC; Chen JY; Liu WC; Lin CH; Kuo CM
    Int Immunopharmacol; 2007 May; 7(5):687-700. PubMed ID: 17386416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of Site of Infection and Antibiotic Selection in the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa Sepsis.
    Britt NS; Ritchie DJ; Kollef MH; Burnham CA; Durkin MJ; Hampton NB; Micek ST
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.